Voxilaprevir

Records for this ingredient, by country (identity only).

ATC — · 11 markets · 14 records

Voxilaprevir 11 markets · 14 records Forms
Filters
Kind

AU 3 records · 1 shown of 1 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Combination products containing this ingredient

  • 100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mg + Voxilaprevir 100 mgVoseviVOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle also in GB·US·CA
    +2Other 2 marketsSGFR
    unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

GB 2 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

Combination products containing this ingredient

  • 100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mg + Voxilaprevir 100 mgVoseviManufacturer: Gilead Sciences Ltd also in AU·US·CA
    +2Other 2 marketsSGFR

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

Combination products containing this ingredient

  • 100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mg + Voxilaprevir 100 mgVosevi also in AU·GB·CA
    +2Other 2 marketsSGFR

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Combination products containing this ingredient

  • 100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mg + Voxilaprevir 100 mgVosevi also in AU·GB·US
    +2Other 2 marketsSGFR

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Combination products containing this ingredient

  • 100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mg + Voxilaprevir 100 mgVosevi also in AU·GB·US
    +2Other 2 marketsCAFR

ES 1 records · 0 shown of 0 Source CIMA (AEMPS) · Data as of live · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

MX 1 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

TW 1 records · 0 shown of 0 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Vosevi ×6沃士維膜衣錠 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室(香港)註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

Combination products containing this ingredient

  • 100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mg + Voxilaprevir 100 mgVOSEVI 400 mg/100 mg/100 mg, comprimé pelliculé also in AU·GB·US
    +2Other 2 marketsCASG

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.